Clinical performance of primary HPV screening cut-off for colposcopy referrals in HPV-vaccinated cohort: Observational study.
HPV
HPV vaccine
cervical screening
colposcopy
Journal
BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
14
06
2022
received:
26
03
2022
accepted:
25
06
2022
pubmed:
3
9
2022
medline:
23
12
2022
entrez:
2
9
2022
Statut:
ppublish
Résumé
To understand the effect of changing from cytology-based to primary HPV screening on the positive predictive value (PPV) of colposcopy referrals for cervical intraepithelial neoplasia (CIN) in a cohort offered HPV vaccination. Retrospective pre/post observational cohort study. Scotland. 2193 women referred to colposcopy between September 2019 and February 2020 from cytology-based screening and between September 2020 and February 2021 from primary high-risk HPV (hrHPV) screening. Calculating positive predictive values (PPVs) for two cohorts of women; one having liquid-based cytology screening and the other, the subsequent hrHPV cervical screening as a pre/post observational study. Positive predictive values of LBC and hrHPV cut-offs for colposcopy referral for CIN at colposcopy. Three papers fitted our criteria; these reported results only for cytology-based screening. The PPV was lower for women in HPV-vaccinated cohorts indicating a lower prevalence of disease. Vaccination under the age of 17 had the lowest PPV reported. Scottish colposcopy data concerning hrHPV and cytology showed a non-significant difference between PPV (17.5%, 95% CI 14.3-20.7, and 20.6, 95% CI 16.7-24.5, respectively) for referrals with a cut-off of low grade dyskaryosis (LGD); both met the standard set of 8-25%. The hrHPV PPV (66.7, 95% CI 56.8-76.6) was comparable to cytology (64.1, 95% CI 55.8-72.4) for referrals with a cut-off of high grade dyskaryosis (HGD) but neither met the standard set of 77-92%. Current literature only provides PPVs for LBC and, overall, the vaccinated cohort had lower PPVs. Only LG dyskaryosis met PHE criteria. The PPV for HPV-vaccinated women undergoing either LBC or HR-HPV screening were not statistically different. However, similar to papers in the current literature, HG dyskaryosis (HGD) PPVs of both techniques did not meet the PHE threshold of 76.6-91.6% outlined in the cervical standards data report.
Identifiants
pubmed: 36054732
doi: 10.1111/1471-0528.17284
pmc: PMC10087227
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
210-213Subventions
Organisme : AFZ Giles scholarship
Informations de copyright
© 2022 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Références
BMJ. 2019 Apr 3;365:l1161
pubmed: 30944092
BJOG. 2016 Jan;123(1):24-38
pubmed: 26099164
Int J Cancer. 2019 Jun 15;144(12):2964-2971
pubmed: 30536935
J Clin Virol. 2021 Apr;137:104756
pubmed: 33662921
Br J Cancer. 2014 Oct 28;111(9):1824-30
pubmed: 25180766
BMC Womens Health. 2011 Jan 20;11:2
pubmed: 21251278
J Fam Plann Reprod Health Care. 2016 Jan;42(1):43-51
pubmed: 26376822
Br J Cancer. 2020 Jul;123(1):155-160
pubmed: 32362659
BJOG. 2022 Jul;129(8):1261-1267
pubmed: 34894043
Br J Cancer. 2016 Mar 1;114(5):582-9
pubmed: 26931370
BMC Med Res Methodol. 2012 Oct 31;12:166
pubmed: 23114025
BJOG. 2017 Aug;124(9):1394-1401
pubmed: 28102931
BJOG. 2017 Aug;124(9):1386-1393
pubmed: 28102928
BJOG. 2023 Jan;130(2):210-213
pubmed: 36054732
Eur J Cancer. 2015 May;51(8):950-68
pubmed: 25817010
Infect Agent Cancer. 2015 Nov 19;10:47
pubmed: 26594236
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252